Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed Apr 16, 2026
Research Summary
AI-generated summary of this filing
CSW INDUSTRIALS CEO Joseph Armes Sells 1,500 Shares
What Happened
Joseph B. Armes, Chairman, President & CEO (and a director) of CSW INDUSTRIALS, sold 1,500 shares of CSW common stock on April 15, 2026. The weighted average sale price was $286.77 per share for total proceeds of $430,151. The sale was made pursuant to a pre-established 10b5-1 trading plan.
Key Details
- Transaction date: 2026-04-15; filing date: 2026-04-16 (appears timely).
- Transaction type/code: Open-market sale (S).
- Shares sold: 1,500; weighted average price: $286.77; total proceeds: $430,151.
- Price range: shares were sold in multiple trades at prices from $283.695 to $302.93 (reporting person will provide per-price breakdown on request).
- Plan disclosure: Sale executed under a 10b5-1 plan established August 12, 2025 (Footnote F1).
- Other footnotes in the filing (F3–F6) describe outstanding performance rights and restricted stock units (long-term incentive awards) that may vest or be settled in cash or shares; these awards were not themselves sold here.
- Shares owned after the transaction: not provided in the excerpt of this filing.
Context
Sales under a 10b5-1 plan are pre-planned and common for insiders managing diversification or liquidity; they do not necessarily indicate a change in view of the company’s prospects. This filing reports a straightforward open-market sale by the CEO.
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-04-15$286.77/sh−1,500$430,151→ 84,494 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 8,004
Performance Rights
[F3]→ Common Stock (8,004 underlying) - 8,236
Performance Rights
[F4]→ Common Stock (8,236 underlying) - 9,186
Performance Rights
[F5]→ Common Stock (9,186 underlying) - 19,685
Restricted Stock Units
[F6]→ Common Stock (19,685 underlying)
Footnotes (6)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $283.695 to $302.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Signature
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes|2026-04-16